137 related articles for article (PubMed ID: 34687742)
1. PLCγ1/PKCθ Downstream Signaling Controls Cutaneous T-Cell Lymphoma Development and Progression.
García-Díaz N; Casar B; Alonso-Alonso R; Quevedo L; Rodríguez M; Ruso-Julve F; Esteve-Codina A; Gut M; Gru AA; González-Vela MC; Gut I; Rodriguez-Peralto JL; Varela I; Ortiz-Romero PL; Piris MA; Vaqué JP
J Invest Dermatol; 2022 May; 142(5):1391-1400.e15. PubMed ID: 34687742
[TBL] [Abstract][Full Text] [Related]
2. Advanced-stage mycosis fungoides: role of the signal transducer and activator of transcription 3, nuclear factor-κB and nuclear factor of activated T cells pathways.
Pérez C; Mondéjar R; García-Díaz N; Cereceda L; León A; Montes S; Durán Vian C; Pérez Paredes MG; González-Morán A; Alegre de Miguel V; Sanz Anquela JM; Frias J; Limeres MA; González LM; Martín Dávila F; Beltrán M; Mollejo M; Méndez JR; González MA; González García J; López R; Gómez A; Izquierdo F; Ramos R; Camacho C; Rodriguez-Pinilla SM; Martínez N; Vaqué JP; Ortiz-Romero PL; Piris MA
Br J Dermatol; 2020 Jan; 182(1):147-155. PubMed ID: 31049933
[TBL] [Abstract][Full Text] [Related]
3. Epigenetic Silencing of Tumor Suppressor miR-124 Directly Supports STAT3 Activation in Cutaneous T-Cell Lymphoma.
García-Colmenero L; González J; Sandoval J; Guillén Y; Diaz-Lagares A; Andrades E; Iglesias A; Nonell L; Pujol RM; Bigas A; Espinosa L; Gallardo F
Cells; 2020 Dec; 9(12):. PubMed ID: 33333886
[TBL] [Abstract][Full Text] [Related]
4. Primary cutaneous T-cell lymphoma (mycosis fungoides and Sézary syndrome): part I. Diagnosis: clinical and histopathologic features and new molecular and biologic markers.
Jawed SI; Myskowski PL; Horwitz S; Moskowitz A; Querfeld C
J Am Acad Dermatol; 2014 Feb; 70(2):205.e1-16; quiz 221-2. PubMed ID: 24438969
[TBL] [Abstract][Full Text] [Related]
5. Clonotypic Diversity of the T-cell Receptor Corroborates the Immature Precursor Origin of Cutaneous T-cell Lymphoma.
Hamrouni A; Fogh H; Zak Z; Ødum N; Gniadecki R
Clin Cancer Res; 2019 May; 25(10):3104-3114. PubMed ID: 30808775
[TBL] [Abstract][Full Text] [Related]
6. Phosphotyrosine-dependent interaction between the kinases PKCθ and Zap70 promotes proximal TCR signaling.
Xie J; Han X; Zhao C; Canonigo-Balancio AJ; Yates JR; Li Y; Lillemeier BF; Altman A
Sci Signal; 2019 Apr; 12(577):. PubMed ID: 30992398
[TBL] [Abstract][Full Text] [Related]
7. T-cell receptor-gamma gene analysis in evolving to advancing cutaneous T-cell lymphoma.
Foo CC; Tang MB; Chong TK; Sun YJ; Tan SH
Australas J Dermatol; 2007 Aug; 48(3):156-60. PubMed ID: 17680965
[TBL] [Abstract][Full Text] [Related]
8. Variants of mycosis fungoides and related cutaneous T-cell lymphomas.
LeBoit PE
Semin Diagn Pathol; 1991 May; 8(2):73-81. PubMed ID: 1871452
[No Abstract] [Full Text] [Related]
9. Jak3, STAT3, and STAT5 inhibit expression of miR-22, a novel tumor suppressor microRNA, in cutaneous T-Cell lymphoma.
Sibbesen NA; Kopp KL; Litvinov IV; Jønson L; Willerslev-Olsen A; Fredholm S; Petersen DL; Nastasi C; Krejsgaard T; Lindahl LM; Gniadecki R; Mongan NP; Sasseville D; Wasik MA; Iversen L; Bonefeld CM; Geisler C; Woetmann A; Odum N
Oncotarget; 2015 Aug; 6(24):20555-69. PubMed ID: 26244872
[TBL] [Abstract][Full Text] [Related]
10. Mycosis fungoides and Sézary syndrome: focus on the current treatment scenario.
Sanches JA; Cury-Martins J; Abreu RM; Miyashiro D; Pereira J
An Bras Dermatol; 2021; 96(4):458-471. PubMed ID: 34053802
[TBL] [Abstract][Full Text] [Related]
11. Notch1 as a potential therapeutic target in cutaneous T-cell lymphoma.
Kamstrup MR; Gjerdrum LM; Biskup E; Lauenborg BT; Ralfkiaer E; Woetmann A; Ødum N; Gniadecki R
Blood; 2010 Oct; 116(14):2504-12. PubMed ID: 20538790
[TBL] [Abstract][Full Text] [Related]
12. Overview of Cutaneous T-Cell Lymphomas.
Larocca CA; LeBoeuf NR
Hematol Oncol Clin North Am; 2019 Aug; 33(4):669-686. PubMed ID: 31229162
[TBL] [Abstract][Full Text] [Related]
13. DUSP22 rearrangement in primary cutaneous T cell lymphoma with features intermediate between mycosis fungoides, anaplastic large-cell lymphoma and lymphomatoid papulosis.
Diaz de la Pinta FJ; Machan S; Manso Alonso R; Carvajal N; Nieves Salgado R; Piris MA; Rodriguez-Pinilla SM
Histopathology; 2022 Jan; 80(2):446-449. PubMed ID: 34252219
[No Abstract] [Full Text] [Related]
14. Hyperprogression of cutaneous T cell lymphoma after anti-PD-1 treatment.
Gao Y; Hu S; Li R; Jin S; Liu F; Liu X; Li Y; Yan Y; Liu W; Gong J; Yang S; Tu P; Shen L; Bai F; Wang Y
JCI Insight; 2023 Feb; 8(4):. PubMed ID: 36649072
[TBL] [Abstract][Full Text] [Related]
15. MicroRNA expression in early mycosis fungoides is distinctly different from atopic dermatitis and advanced cutaneous T-cell lymphoma.
Ralfkiaer U; Lindahl LM; Litman T; Gjerdrum LM; Ahler CB; Gniadecki R; Marstrand T; Fredholm S; Iversen L; Wasik MA; Bonefeld CM; Geisler C; Krejsgaard T; Glue C; Røpke MA; Woetmann A; Skov L; Grønbæk K; Odum N
Anticancer Res; 2014 Dec; 34(12):7207-17. PubMed ID: 25503151
[TBL] [Abstract][Full Text] [Related]
16. Role of Dysregulated Cytokine Signaling and Bacterial Triggers in the Pathogenesis of Cutaneous T-Cell Lymphoma.
Fanok MH; Sun A; Fogli LK; Narendran V; Eckstein M; Kannan K; Dolgalev I; Lazaris C; Heguy A; Laird ME; Sundrud MS; Liu C; Kutok J; Lacruz RS; Latkowski JA; Aifantis I; Ødum N; Hymes KB; Goel S; Koralov SB
J Invest Dermatol; 2018 May; 138(5):1116-1125. PubMed ID: 29128259
[TBL] [Abstract][Full Text] [Related]
17. High Expression of IKZF2 in Malignant T Cells Promotes Disease Progression in Cutaneous T Cell Lymphoma.
Xu B; Liu F; Gao Y; Sun J; Li Y; Lin Y; Liu X; Wen Y; Yi S; Dang J; Tu P; Wang Y
Acta Derm Venereol; 2021 Dec; 101(12):adv00613. PubMed ID: 34853863
[TBL] [Abstract][Full Text] [Related]
18. Role of B-cells in Mycosis Fungoides.
Nielsen PR; Eriksen JO; Sørensen MD; Wehkamp U; Lindahl LM; Bzorek M; Iversen L; Woetman A; Ødum N; Litman T; Gjerdrum LMR
Acta Derm Venereol; 2021 Mar; 101(3):adv00413. PubMed ID: 33686443
[TBL] [Abstract][Full Text] [Related]
19. Constitutive activation of a slowly migrating isoform of Stat3 in mycosis fungoides: tyrphostin AG490 inhibits Stat3 activation and growth of mycosis fungoides tumor cell lines.
Nielsen M; Kaltoft K; Nordahl M; Röpke C; Geisler C; Mustelin T; Dobson P; Svejgaard A; Odum N
Proc Natl Acad Sci U S A; 1997 Jun; 94(13):6764-9. PubMed ID: 9192639
[TBL] [Abstract][Full Text] [Related]
20. IL-15 and IL-17F are differentially regulated and expressed in mycosis fungoides (MF).
Willerslev-Olsen A; Litvinov IV; Fredholm SM; Petersen DL; Sibbesen NA; Gniadecki R; Zhang Q; Bonefeld CM; Wasik MA; Geisler C; Zhou Y; Woetmann A; Sasseville D; Krejsgaard T; Odum N
Cell Cycle; 2014; 13(8):1306-12. PubMed ID: 24621498
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
